🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with tirzepatide cardiovascular safety? Page 4

Has anyone dealt with tirzepatide cardiovascular safety?

carlos_SATX Mon, Jun 23, 2025 at 10:20 PM 41 replies 1,657 viewsPage 4 of 9
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Jun 24, 2025 at 4:00 AM#16

Just wanted to say — for anyone reading this Has anyone dealt thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Jun 24, 2025 at 7:00 AM
11 15pete_nash, hank_denver, carlos_SATX and 8 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Jun 24, 2025 at 4:17 AM#17

carlos_SATX's experience with Has anyone dealt with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 54 lbs in 9 months.

One thing I would add that carlos_SATX did not mention: the mental health improvements were just as significant.

29 18julia.endo, JessicaM_2024, TomFromTexas and 26 others
Reply Quote Save Share Report
mike_mealprep
Member
412
1,890
Jul 2024
Chicago, IL
Jun 24, 2025 at 4:34 AM#18

Saving this for reference. Top-tier content.

30 5Dr.AddMedPHL, newstart_MO, mia_MS2 and 27 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Jun 24, 2025 at 4:51 AM#19

As a pharmacist, I want to add some clinical context to this discussion on Has anyone dealt with tirzepatide.

Building on what carlos_SATX said — the evidence base here is robust. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
7 15Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 4 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Jun 24, 2025 at 5:08 AM#20

Subscribing to this thread. Has anyone dealt with is exactly what I've been researching. 🙏

46 22SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 43 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register